TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
about
Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis.TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD.Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist.
P2860
TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
@en
TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
@nl
type
label
TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
@en
TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
@nl
prefLabel
TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
@en
TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
@nl
P2093
P2860
P356
P1433
P1476
TM6SF2 rs58542926 impacts lipid processing in liver and small intestine
@en
P2093
Alexis Gorden
Carmen C Leitch
Carole Sztalryd
Christopher D Still
Elizabeth A O'Hare
G Craig Wood
Glenn S Gerhard
Janet D Robishaw
Kathy A Ryan
Laura M Yerges-Armstrong
P2860
P304
P356
10.1002/HEP.29021
P407
P577
2017-03-22T00:00:00Z